0.00Open0.00Pre Close0 Volume0 Open Interest45.00Strike Price0.00Turnover3052.96%IV-42.09%PremiumDec 13, 2024Expiry Date32.71Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9734Delta0.0026Gamma2.36Leverage Ratio-18.7921Theta0.0000Rho2.30Eff Leverage0.0005Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet